Purpose: Cell adhesion molecule integrin a v b 3 is an excellent target for tumor interventions because of its unique expression on the surface of several types of solid tumor cells and on almost all sprouting tumor vasculatures. Here, we describe the development of near-infrared (NIR) fluorochrome Cy7-labeled RGD peptides for tumor integrin targeting. Procedures: Mono-, di-, and tetrameric RGD peptides were synthesized and conjugated with Cy7. The integrin specificity of these fluorescent probes was tested in vitro for receptor binding assay and fluorescence microscopy and in vivo for subcutaneous U87MG tumor targeting. Results: The tetrameric RGD peptide probe with the highest integrin affinity showed the highest tumor activity accumulation and strongest tumor-to-normal tissue contrast. This uptake is integrin-specific as the signal accumulated in the tumor can be effectively blocked by unconjugated RGD peptide antagonist of integrin a v b 3 . Conclusions: Noninvasive NIR fluorescence imaging is able to detect and semiquantify tumor integrin expression based upon the highly potent tetrameric RGD peptide probe.
Introduction

I
ntegrins are a family of adhesion molecules consisting of two noncovalently bound transmembrane subunits (a and b), both type I membrane proteins with large extracellular segments that pair to create heterodimers with distinct adhesive capabilities [1, 2] . In mammals, 18 a and 8 b subunits assemble into 24 different receptors. Increasing amounts of evidence now imply that integrin signaling plays a key role in tumor angiogenesis and metastasis [3Y5] . Integrins expressed on endothelial cells modulate cell migration and survival during angiogenesis while integrins expressed on carcinoma cells potentiate metastasis by facilitating invasion and movement across blood vessels. Efficient tumor invasion requires partial degradation of the extracellular matrix (ECM) at the invasion front. Matrix metalloproteinases (MMPs) are the major proteases involved in remodeling the ECM [6] . The a v b 3 integrin, which binds to arginineYglycineYaspartic acid (RGD)-containing components of the interstitial matrix (such as vitronectin, fibronectin, and thrombospondin), is significantly up-regulated on endothelium during angiogenesis but not on quiescent endothelium [2, 5, 7] . The special role of integrin a v b 3 in tumor invasion and metastasis arises from its ability to recruit and activate MMP-2 and plasmin, which degrade components of the basement membrane and interstitial matrix [8] . Research has shown that tumor expression of integrin a v b 3 correlates well with tumor progression in several malignancies such as melanoma [9] , glioma [10] , and ovarian [11] and breast cancer [12, 13] . Inhibition of a v integrin activity by monoclonal antibodies (mAbs), cyclic RGD peptide antagonists, and peptidomimetics has also been shown to induce endothelial cell apoptosis [14] , inhibit angiogenesis, and increase endothelial monolayer permeability [15] .
The ability to noninvasively visualize and quantify integrin a v b 3 expression level will provide new opportunities to document tumor (tumor cells and sprouting tumor vasculature) integrin expression, to more appropriately select patients for anti-integrin treatment and to monitor treatment efficacy in integrin-positive patients [16] . Contrast-enhanced ultrasound with microbubbles targeted to a v integrins expressed on the neovascular endothelium has been used to image tumor integrin status in addition to tumor microvascular blood volume and blood velocity, which can be easily detected with nontargeted microbubbles [17, 18] . Paramagnetic nanoparticles have also been coated with either antibodies or small peptidic/peptidomimetic integrin a v b 3 antagonists to visualize leaky tumor neovasculature and proliferative angiogenic vessels in atherosclerosis [19, 20] . Various RGD peptides have also been labeled with gamma-emitting radioisotopes (such as 99m Tc and 111 In) for single-photon emission computed tomography (SPECT) and with positron-emitting radionuclides (such as 18 F and 64 Cu) for positron emission tomography (PET) imaging applications [10, 12, 13, 21Y25] .
Recently, we and others [26Y28] have shown that nearinfrared (NIR) fluorescent dyes conjugated cyclic RGD peptides were able to visualize subcutaneously inoculated integrin-positive tumors. In vivo imaging with a prototype three-dimensional small-animal imaging system allowed delineation of U87MG glioblastoma xenograft with high contrast with a wide range of concentrations of Cy5.5-labeled monomeric RGD peptide c(RGDyK) [26] . Another RGD peptide with slightly different sequences c(RGDfK) was also coupled with Cy5.5 for KS167 Kaposi's sarcoma and with IRDye800 for M21 melanoma imaging with success [27, 28] . It is also noteworthy that a presumably inactive linear hexapeptide GRDSPK, after conjugation with an NIR carbocyanine molecular probe (Cypate), turns into a previously undescribed bioactive ligand (Cyp-GRD) that targets integrin-positive tumors [29] .
Monomeric RGD peptide with moderate integrin receptor affinity after being labeled with radionuclides or fluorescent dyes resulted in relatively low tumor uptake and tumor-tobackground contrast [10, 12, 24, 25] . Since the monomeric RGD peptide in the bent configuration has already been optimized to fit into the deep cleft between the a and b units of integrin a v b 3 , it is very unlikely that one can further improve integrin affinity and selectivity of the monomer by fine-tuning the pentapeptide configuration [2, 30] . Polyvalency effect [31, 32] has thus been applied to develop dimeric and tetrameric RGD peptides, with repeating cyclic pentapeptide units connected by glutamates. The dimeric RGD peptide E[c(RGDyK)] 2 with almost 1 order-of-magnitude higher binding affinity than the corresponding monomer c(RGDyK) was then labeled with 18 F and 64 Cu. Significantly increased tumor uptake and prolonged activity accumulation of the dimeric RGD peptide tracers [13, 22, 23] in the integrin-positive tumors prompted us to develop a tetrameric RGD peptide E{E[c(RGDfK)] 2 } 2 [33] . Noninvasive microPET imaging studies with 64 Cu-DOTA-E{E [c(RGDfK)] 2 } 2 showed significant tumor uptake (up to 10% ID/g) and excellent tumor-to-background contrast of this radiotracer in the subcutaneous tumor-bearing mice. The presumed polyvalency effect and suitable apparent size of this tetrameric RGD peptide make it a superior ligand for integrin targeting in vivo. Despite the obviously improved tumor targeting efficacy of radiolabeled RGD tetramer as opposed to the dimers and monomers, fluorescent dye Cy5.5-conjugated tetramer had only moderate improvement of imaging character than the corresponding monomeric counterpart [34] . In this study, we wanted to assess whether dimeric and tetrameric RGD peptides, when labeled with NIR fluorescent dye Cy7, will be superior to the monomeric RGD peptide probe Cy7-c (RGDyK) in terms of tumor targeting efficacy and in vivo pharmacokinetics. 
Materials and Methods
Materials
Synthesis of Cyclic Pentapeptide c(RGDyK)
Monomeric cyclic RGD peptide c(RGDyK) was synthesized as previously reported [35] with slight modification. The fully protected linear pentapeptide H-D-Tyr(OtBu)-Lys(Boc)-Arg(Pbf)-Gly-Asp(OtBu)-OH was cleaved from the resin by HFIP/DCM (3:7, v:v) without affecting the side-chain protecting groups. Headto-tail cyclization was carried out in DMF solution (1 mg/mL) with BOP (3 eq.), HOBt (3 eq.), and DIPEA (6.6 eq.) at pH õ8.5. All side-chain protecting groups were then removed by TFA/H 2 O/ anisole/DCM (90:5:2.5:2.5) at room temperature for one hour. The crude cyclic pentapeptide was purified by preparative reversedphase high-performance liquid chromatography (HPLC, Dionex Summit \ HPLC system; Dionex Corporation, Sunnyvale, CA, USA) using a Vydac protein and peptide column (218TP101522, 10Y15 mm, 250 Â 22 mm). The flow rate was 10 mL/min with the mobile phase changing from 95% solvent A (0.1% TFA in water) and 5% solvent B (0.1% TFA in acetonitrile) (0Y10 minutes) to 35% solvent A and 65% solvent B at 40 
Synthesis of Cy7-RGD Conjugates
Cell Culture
Human glioblastoma U87MG cell line was obtained from American Type Culture Collection (Manassas, VA, USA) and was cultured at 37-C in a humidified atmosphere containing 5% CO 2 in Iscove's modified Dulbecco's medium supplemented with 5% fetal bovine serum (Life Technologies, Inc., Grand island, NY, USA) and 1 mM sodium pyruvate.
Cell Integrin Receptor Binding Assay
In vitro integrin-binding affinities and specificities of the Cy7-conjugated RGD peptides were evaluated via displacement cell-binding assays using 125 I-echistatin as the integrin-specific radioligand. U87MG cells were harvested, washed twice with phosphate-buffered saline (PBS), and resuspended (2 Â 10 6 cells/ mL) in binding buffer (20 mM Tris, pH = 7.4, 150 mM NaCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 1 mM MnCl 2 , and 0.1% bovine serum albumin). 96-well multiscreen DV plates (filter pore size: 0.65 mm; Millipore, Billerica, MA, USA) were seeded with 10 5 cells and incubated with 125 I-echistatin (30,000 cpm/well) in the presence of increasing concentrations of different Cy7-conjugated RGD peptides (0Y1,000 nM). The final volume was adjusted to 200 mL/well. After the cells were incubated for two hours at room temperature, the binding buffer was removed by vacuum. ReceptorYligand complex trapped on filters was washed three times with 200 mL ice-cold binding buffer. The hydrophilic PVDF filters were collected and the radioactivity was measured by using a NaI(Tl) gamma counter (Packard, Meriden, CT, USA). The best-fit IC 50 values were calculated by fitting the data by nonlinear regression using GraphPad Prism i (GraphPad Software, Inc., San Diego, CA, USA). Experiments were carried out twice with triplicate samples.
Cell Staining
U87MG cells were seeded on 35 mm MatTek glass bottom culture dishes. After 48 hours, the cells were washed twice with warm binding buffer and then incubated at 37-C with appropriate Cy7-RGD conjugate (1 mM) in binding buffer for 30 minutes. For the blocking study, unconjugated RGD peptide c(RGDyK) (20 mM) was added to the culture medium before the addition of Cy7-RGD conjugates. After incubation for 30 minutes, the cells were washed three times with ice-cold binding buffer. Fluorescence microscopy experiments were carried out by using a Zeiss Axiovert 200M fluorescence microscope (Carl Zeiss MicroImaging, Inc., Thornwood, NY, USA). A custom Cy7 filter set was used (excitation: 730/40 nm; emission: 770/40 nm; dichroic mirror: 760 nm; Omega Optical, Brattleboro, VT, USA).
Animal Models
Animal studies were performed according to a protocol approved by Stanford's Administrative Panel on Laboratory Animal Care (A-PLAC). Female athymic nude mice (nu/nu) (four to six weeks old; Harlan, Inc., Indianapolis, IN, USA) were housed five per cage and fed with sterilized pellet chow and sterilized water. Mice were anesthetized in an isoflurane chamber before being injected subcutaneously in the right foreleg with 5 Â 10 6 U87MG cells suspended in 50 mL sterile PBS. Three to four weeks after inoculation, when the tumors reached 0.5Y0.8 cm in diameter, the mice were used for in vivo imaging studies.
In vivo NIR Fluorescence Imaging
In vivo NIR fluorescence imaging was performed with an Xenogen IVIS i 200 small animal imaging system (Xenogen, Alameda, CA, USA) with a Cy7 filter set (excitation: 680/30 nm; emission: 775/ 30 nm). The surface fluorescence intensity of the animal was measured and normalized to photons per second per centimeter squared per steradian (p/s/cm 2 /sr). Mice (n = 3 for each Cy7-RGD conjugate) were injected via tail vein with 500 pmol Cy7-RGD (mono-, di-, or tetramer), anesthetized, and imaged at various time points postinjection (p.i.). All fluorescence images were acquired with one second exposure (f/stop = 4). For receptor specificity study, mice injected with 500 pmol of the Cy7-RGD conjugate with or without coinjection of unconjugated c(RGDyK) (200 mg/mouse) were imaged at two hours, p.i., and then immediately euthanized by inhalation of carbon dioxide. The tumors and major organs and tissues were dissected and imaged again. The total fluorescence flux (p/s/cm 2 /sr) for each organ was measured. For quantitative comparison, regions of interests (ROIs) were drawn over tumor and normal tissues and the results were presented as mean T standard deviation (SD) for a group of three animals.
Serum Stability
Cy7-RGD conjugate was incubated at 37-C in complete mouse serum (Sigma, St. Louis, MO, USA) and the fluorescence intensity was measured by using a FluoroMax-3 instrument (Jobin Yvon Inc., Edison, NJ, USA). Excitation wavelength was set at 720 nm and emission scan range was 750Y790 nm. Relative fluorescence intensity at 775 nm over time was plotted.
Statistical Analysis
One-way analysis of variance (ANOVA) was used for statistical evaluation. Means were compared by using Student's t-test. P value of G0.05 was considered significant.
Results
Synthesis of Cy7YRGD Conjugates
Cy7-labeled RGD peptides (Fig. 1) 
Cell Integrin Receptor Binding Assay
Receptor binding assay using integrin-positive U87MG cells and 125 I-echistatin as radioligand revealed that all the peptides inhibited the binding of 125 I-echistatin to the cell surface integrin receptor [24] (results are shown in Fig. 2 ). The affinity of the RGD peptides for integrin a v b 3 follows the order of E{E[c(RGDyK)] 2 } 2 9 E[c(RGDyK)] 2 9 c(RG DyK). Cy7 conjugation had minimal disturbance on the receptor (Table 1) . P values were less than 0.01 when comparing Cy7-c(RGDyK) with the other two conjugates, whereas the IC 50 values for Cy7-E[c(RGDyK)] 2 and Cy7-E{E[c(RGDyK)] 2 } 2 was not statistically different (P = 0.10).
Cell Staining
We examined the a v b 3 integrin specificity of the three Cy7-RGD conjugates. Prominent fluorescence signal was observed for cells stained with each of the three conjugates (Fig. 3FYH) . In contrast, only weak signal was detected when the cells were incubated with the unconjugated Cy7 dye (Fig. 3E) . It is also of note that fluorescence intensity of the stained cells follows the order of Cy7-E{E[c(RGDyK)] 2 } 2 9 Cy7-E[c(RGDyK)] 2 9 Cy7-c(RGDyK), corresponding with the integrin binding affinity of the conjugates. Incubation of cells with Cy7-RGD probes in the presence of a blocking dose of monomeric RGD peptide c(RGDyK) (20 mM) led to complete disappearance of cell-associated fluorescence (Fig. 3NYP) . However, the RGD peptide had virtually no affect on the cellular uptake of Cy7 (Fig. 3M) . This result further confirms the integrin a v b 3 specific binding of all three Cy7YRGD conjugates. (Fig. 4) . The fluorescence intensity in the tumor as a function of time is plotted in Fig. 5A . As can be seen from Figs Fig. 7A and B, it can be clearly seen that the difference in tumor fluorescence intensity between the BExperiment^and BBlock^animals is significantly larger ex vivo (Fig. 7B ) than in vivo (Fig. 7A) , attributed to the absence of autofluorescence and scattering by the skin. Serum stability experiments demonstrated that the fluorescence signal of all three Cy7-RGD conjugates remained stable for 24 hours (Fig. 7C) , clearly indicating that the fluorescence signal loss over time was attributable to the clearance of the Cy7-RGD conjugates.
In vivo NIR Fluorescence Imaging
Discussion
Despite the fact that integrin a v b 3 affinity of the three RGD peptide follows the order of tetramer 9 dimer 9 monomer, separate docking studies based on the crystal structure of the extracellular segment of integrin a v b 3 [30] and its complex with cyclic RGD peptide c(RGDf(NMe)V) [2] did not show the advantage of dimeric and tetrameric RGD peptides over monomeric RGD peptide based on the similar docking space (our unpublished results). We speculate that the observed higher affinity of tetramer over dimer, and dimer over monomer is likely related to receptor clustering. It has been shown that integrin clustering [36] is able to assemble multiple cytoplastic regulatory and structural proteins at sites of aggregated integrin cytoplasmic domains, activating certain intracellular signaling pathways. The presence of an integrin ligand with multimeric receptor binding sites also results in more efficient clustering of the ligand-bound integrins compared to the same surface density of ligand presented individually. We reason that dimeric and tetrameric RGD peptides tethered through glutamate linker(s) may locate the ligand in a manner in which binding of the first cyclic RGD peptide to one receptor will enhance the binding of the remaining RGD peptides in the vicinity to the other binding domains of the same receptor or to other closely clustered receptor subunits. It is also of note that unconjugated Cy7 dye gives prominent tumor-to-background contrast. It has been reported that some fluorescent dyes are capable of tumor accumulation and have been investigated as potential contrast agents for the detection of tumors in both animal models and in humans. Such contrast is most likely attributable to passive targeting where bulky dye molecules diffuse more into the more permeable tumor vasculature as compared to normal vessels [37Y39]. On the other hand, the fact that RGD peptide failed to block the tumor contrast induced by unconjugated Cy7 confirms the passive targeting of the fluorescent dye (data not shown).
The fluorescence intensity of the dissected tumors was significantly higher than that measured by ROI analysis of the noninvasive images. The extent of difference for the Cy7 conjugates, however, is less than that found for the Cy5.5 analogs [26] . This can be explained by the fact that Cy7 with longer wavelength absorption and emission provides deeper tissue penetration than Cy5.5 [40] , which leads to less attenuation of fluorescence signal in vivo as compared to ex vivo quantification. Tumor-to-muscle ratio by ex vivo analysis was also much higher than the T/N ratio by analyzing the in vivo imaging data ( Fig. 7A and B) . Higher tumor/muscle contrast ex vivo may be explained by the more effective fluorescence detection of excised organs and tissues without attenuation of the excitation and emission light in and out of the skin as well as the scattering caused by the skin.
Cy7-conjugated RGD peptides exhibit more rapid tumor washout compared to the Cy5.5 analogs. Because Cy7 has only two sulfonate groups while Cy5.5 has four sulfonates on the aromatic rings, Cy5.5 is more hydrophilic than Cy7 and thus has reduced plasma protein binding and slower clearance by the liver, resulting in prolonged tumor retention of Cy5.5 than Cy7. Further development of NIR fluorochromes with better bioavailability (metabolic stability and hydrophilicity) and optical properties (high quantum yield and large Stokes shift) is needed to achieve better tumor integrin targeting of RGD peptide-based optical probes. It is also worth mentioning that we applied 2D imaging technology in this study. The imaging result can only be interpreted semiquantitatively. Fluorescence-mediated tomography [41] that is able to recover the spatial distribution of light emitting fluorophore and to quantify the nonuniform quantum yield distribution/fluorophore absorption within biological tissue may give more quantitative results.
Conclusions
The expression of integrin a v b 3 on sprouting capillary cells and its interactions with specific matrix ligands is essential for tumor angiogenesis and metastasis. Noninvasive imaging of integrin expression plays a key role in evaluating tumor angiogenesis and assessing antiangiogenic treatment efficacy. The studies described above demonstrate that it is feasible to detect and semiquantify tumor integrin status by noninvasive near-infrared fluorescence imaging. The tumor contrast of the resulting optical probes is related to the receptor affinity, overall molecular size, hydrophilicity, and fluorescence efficiency. Despite the limited penetration of light through tissue, this approach provides opportunities for rapid and cost-effective preclinical evaluation in animal models before the more costly radionuclide-based imaging techniques. In clinical settings, NIR fluorescence imaging may still be useful to delineate lesions that are near the surface (such as melanoma and breast cancer). Such technique will also be useful for fluorescence-guided surgery [42] via sensitive, specific, and real-time intraoperative visualization of molecular features of normal and diseased processes.
